IDA blend vs Zimbabwe: Access to anti-retroviral drugs, male
IDA blend
74.0%
in 2024
Zimbabwe
89.0%
in 2024
IDA blend rank
14th
Zimbabwe rank
17th
Access to anti-retroviral drugs, male over time
- IDA blend
- Zimbabwe
How they compare
Zimbabwe currently reports 89.0% against 74.0% in IDA blend, a difference of 15.0%.
That makes Zimbabwe's figure about 1.2 times IDA blend's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Zimbabwe ahead.
IDA blend ranks 14th and Zimbabwe ranks 17th of 19 groups.
Across the 3 decades both report, IDA blend averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | IDA blend | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 4.1% | 1.4% | IDA blend |
| 2010s | 38.5% | 52.9% | 14.4% | Zimbabwe |
| 2020s | 67.7% | 88.4% | 20.7% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA blend or Zimbabwe?
- Zimbabwe, at 89.0% against 74.0% in IDA blend as of 2024.
- What is the difference in access to anti-retroviral drugs, male between IDA blend and Zimbabwe?
- 15.0%, with Zimbabwe ahead.
- How many years of comparable data are there for IDA blend and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA blend and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- IDA blend ranks 14th and Zimbabwe ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.